Japan
· Delayed Price · Currency is JPY SymBio Pharmaceuticals Statistics
Total Valuation
TYO:4582 has a market cap or net worth of JPY 7.79 billion. The enterprise value is 4.88 billion.
| Market Cap | 7.79B |
| Enterprise Value | 4.88B |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:4582 has 48.71 million shares outstanding. The number of shares has increased by 13.09% in one year.
| Current Share Class | 48.71M |
| Shares Outstanding | 48.71M |
| Shares Change (YoY) | +13.09% |
| Shares Change (QoQ) | +3.13% |
| Owned by Insiders (%) | 6.45% |
| Owned by Institutions (%) | -0.65% |
| Float | 44.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.68 |
| PB Ratio | 2.29 |
| P/TBV Ratio | 2.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.11 |
| EV / Sales | 2.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.20, with a Debt / Equity ratio of 0.21.
| Current Ratio | 8.20 |
| Quick Ratio | 6.78 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -74.11 |
Financial Efficiency
Return on equity (ROE) is -84.21% and return on invested capital (ROIC) is -47.76%.
| Return on Equity (ROE) | -84.21% |
| Return on Assets (ROA) | -42.79% |
| Return on Invested Capital (ROIC) | -47.76% |
| Return on Capital Employed (ROCE) | -103.33% |
| Revenue Per Employee | 19.62M |
| Profits Per Employee | -40.53M |
| Employee Count | 108 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 2.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.52% in the last 52 weeks. The beta is 0.31, so TYO:4582's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +2.52% |
| 50-Day Moving Average | 160.64 |
| 200-Day Moving Average | 213.01 |
| Relative Strength Index (RSI) | 58.44 |
| Average Volume (20 Days) | 200,580 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TYO:4582 had revenue of JPY 2.12 billion and -4.38 billion in losses. Loss per share was -94.88.
| Revenue | 2.12B |
| Gross Profit | 1.60B |
| Operating Income | -4.24B |
| Pretax Income | -4.34B |
| Net Income | -4.38B |
| EBITDA | n/a |
| EBIT | -4.24B |
| Loss Per Share | -94.88 |
Balance Sheet
The company has 3.61 billion in cash and 700.00 million in debt, giving a net cash position of 2.91 billion or 59.84 per share.
| Cash & Cash Equivalents | 3.61B |
| Total Debt | 700.00M |
| Net Cash | 2.91B |
| Net Cash Per Share | 59.84 |
| Equity (Book Value) | 3.40B |
| Book Value Per Share | 69.77 |
| Working Capital | 4.06B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.72%, with operating and profit margins of -200.06% and -206.58%.
| Gross Margin | 75.72% |
| Operating Margin | -200.06% |
| Pretax Margin | -204.82% |
| Profit Margin | -206.58% |
| EBITDA Margin | n/a |
| EBIT Margin | -200.06% |
| FCF Margin | n/a |
Dividends & Yields
TYO:4582 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.09% |
| Shareholder Yield | -13.09% |
| Earnings Yield | -56.17% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 26, 2019. It was a reverse split with a ratio of 0.25.
| Last Split Date | Jun 26, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
TYO:4582 has an Altman Z-Score of -7.12. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.12 |
| Piotroski F-Score | n/a |